Vol 28, No 1 (2021)
Brief communication — Clinical cardiology
Published online: 2021-01-11

open access

Page views 759
Article views/downloads 745
Get Citation

Connect on Social Media

Connect on Social Media

Effects of intracoronary antithrombotics on ventricular function: A comparison of tenecteplase versus abciximab during primary percutaneous intervention in myocardial infarction

Francisco J. Morales-Ponce1, Pablo González-Pérez1, Sara Blasco-Turrión1, Juan Antonio Sánchez-Brotons1, Carmen Collado-Moreno1, Pedro Martínez-Romero1, Eduardo Martínez-Morentín1, Pilar Caro-Mateo2
Pubmed: 33438179
Cardiol J 2021;28(1):176-178.

Abstract

Not available

Article available in PDF format

View PDF Download PDF file

References

  1. Stone GW, Maehara A, Witzenbichler B, et al. Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial. JAMA. 2012; 307(17): 1817–1826.
  2. Morales-Ponce FJ, Lozano-Cid FJ, Martinez-Romero P, et al. Intracoronary tenecteplase versus abciximab as adjunctive treatment during primary percutaneous coronary intervention in patients with anterior myocardial infarction. EuroIntervention. 2019; 14(16): 1668–1675.
  3. Prastaro M, Pirozzi E, Gaibazzi N, et al. Expert review on the prognostic role of echocardiography after acute myocardial infarction. J Am Soc Echocardiogr. 2017; 30(5): 431–443.e2.
  4. McCartney PJ, Maznyczka AM, Eteiba H, et al. Low-Dose alteplase during primary percutaneous coronary intervention according to ischemic time. J Am Coll Cardiol. 2020; 75(12): 1406–1421.